IVAX Diagnostics, Inc. (NYSE Amex:IVD) today reported that, in light of the unusual market activity in its stock, the NYSE Amex contacted IVAX Diagnostics in accordance with the NYSE Amex’s usual practice. IVAX Diagnostics confirmed that its policy is not to comment on unusual market activity.

About IVAX Diagnostics, Inc.

IVAX Diagnostics, Inc. (www.ivaxdiagnostics.com), headquartered in Miami, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and instrumentation, primarily for autoimmune and infectious diseases, through its three subsidiaries: Diamedix Corporation (U.S.), Delta Biologicals S.r.l. (Europe), and ImmunoVision, Inc. (U.S.).

Grafico Azioni Ivax Diagnostics (AMEX:IVD)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Ivax Diagnostics
Grafico Azioni Ivax Diagnostics (AMEX:IVD)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Ivax Diagnostics